Progression of Hodgkin lymphoma and plasma cell neoplasms Report from the 2021 SH/EAHP Workshop

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Compare the genetic alterations seen in classical Hodgkin lymphoma (cHL) with those detected in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Compare the genetic alterations seen in classical Hodgkin lymphoma (cHL) with those detected in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
List the common genetic alterations found in plasma cell myeloma, including primary events and secondary changes.
Apply molecular and clonality studies in work-up of malignant hematopoietic diseases arising in a background of Hodgkin lymphoma or plasma cell myeloma.

View More View Less